KELLEY SHANNON T (General Counsel) sold 7.5% of their position (692.00 shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $344.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/20/2026ACC: 0001628280-26-002742
Officer· General Counsel
Since Mar 2026
-692.00
Net shares
Net seller
$344.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
692.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−263.00
Price / share
$490.77
Trade value
$129.07K
% of position
2.9%
1/20/2026
9.17K→8.91K
Common Stock
Direct
Shares
−429.00
Price / share
$501.40
Trade value
$215.10K
% of position
4.8%
1/20/2026
8.91K→8.48K
Total
Net shares
−692.00
Net value
-$344.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/20/2026 | S · Sale | −263.00 | $490.77 | $129.07K | 2.9% | 9.17K | 8.91K |
| Common Stock Direct | 1/20/2026 | S · Sale | −429.00 | $501.40 | $215.10K | 4.8% | 8.91K | 8.48K |
| Total | −692.00 | -$344.17K | ||||||
Derivative Transactions0
No derivative transactions reported